Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 6 | Longs Won 2/6 33% | Profit Factor 0.73 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $20,132.16 |
| Average Win $18,513.63 | Best Trade (May 16) $25,944.17 | Sharpe Ratio -10.21 |
| Average Loss -$12,690.37 | Worst Trade (Oct 15) -$33,941.37 | Z-Score -1.24 (78.54%) |
| Commissions $0 | Avg. Trade Length 4w 1d | Expectancy -$1,160.36 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 7 | 7 | 6 | 5 | 4 | 4 | 3 | 2 | 1 | 1 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
IMUX Immunic, Inc. | 13,103.92 | $96,313.82 | $93,037.84 | - | -$3,275.98 | -3.4% | -4.184% |